首页 | 本学科首页   官方微博 | 高级检索  
     

遗传性乳腺癌-卵巢癌综合征中BRCA1/2的表达
引用本文:李天人,畅 华,郭科军. 遗传性乳腺癌-卵巢癌综合征中BRCA1/2的表达[J]. 解剖科学进展, 2014, 0(3): 233-236
作者姓名:李天人  畅 华  郭科军
作者单位:中国医科大学附属第一医院妇科,辽宁沈阳110001
摘    要:目的检测BRCA1/2在遗传性乳腺癌-卵巢癌综合征(HBOC)患者所患卵巢癌和散发性卵巢癌组织中蛋白表达的差异,探讨其在HBOC患者卵巢癌发病中的意义。方法收集我院妇科2001年1月至2010年10月HBOC患者卵巢癌40例和散发性卵巢癌20例(对照组)的石蜡组织标本,行免疫组化检测BRCA蛋白的表达;收集2011年1月-2013年12月HBOC卵巢癌11例和同期散发性卵巢癌10例(对照组)的新鲜标本,行Western Blot检测BRCA蛋白的表达。结果免疫组化结果显示HBOC组BRCA2蛋白阳性产物OD值(0.64±0.013)明显高于对照组(0.24±0.002,0.05)。Western blot结果显示HBOC组BRCA2蛋白OD值(0.68±0.02)明显高于对照组(0.26±0.01,0.05)。但是,对于BRCA1没有明显区别。结论 BRCA2蛋白在HBOC患者卵巢癌组织过表达提示BRCA2可能与HBOC的发病相关。

关 键 词:卵巢肿瘤  遗传性乳腺癌-卵巢癌综合征  BRCA1  BRCA2

The expression of BRCA1/2 in patients with hereditary breast and ovarian cancer syndrome
LI Tian-ren,CHANG Hua,GUO Ke-jun. The expression of BRCA1/2 in patients with hereditary breast and ovarian cancer syndrome[J]. Progress of Anatomical Sciences, 2014, 0(3): 233-236
Authors:LI Tian-ren  CHANG Hua  GUO Ke-jun
Affiliation:( Department of Gynecology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China )
Abstract:Objective To study the expression of BRCA1/2 in ovarian cancers and sporadic ovarian cancers of patients with hereditary breast and ovarian cancer syndrome(HBOC). Methods The BRCA1/2 expressions in ovarian cancers and sporadic ovarian cancers(controls) of HBOC were detected by immunohistochemistry and Western blot, and analyzed statistically. Results Both of immunohistochemistry and Western blot analysis showed that the positive expression level of BRCA2 was significantly higher in HBOC ovarian cancers than in the control group(P〈0.05), but with no obvious difference for BRCA1. Conclusion The overexpression of BRCA2 in HBOC ovarian cancers indicates that BRCA2 might be related to the pathogenesis of HBOC.
Keywords:Ovarian neoplasms  hereditary breast and ovarian cancer syndrome  BRCA1  BRCA2
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号